Hinduja Global Solutions Ltd.

Similar documents
HDFC Bank Ltd. BUY. Investment Rationale. July 2, Volume No.. 1 Issue No. 28

MindTree Ltd. Investment Rationale. For private circulation only. October 7 th, Volume No. I. Issue No. 43

Apollo Hospitals Enterprise Ltd.

Larsen & Toubro Ltd.

GIC Housing Finance Ltd.

Infosys Ltd. BUY. Investment Rationale. Volume No.. 1 Issue No. 26. June 24, 2015

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

APOLLO TYRES LTD. October 19 th, CMP (Rs.) 194. Key Developments

State Bank of India (SBI)

Maruti Suzuki India Ltd.

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

Religare Investment Call

JK Tyre & Industries Ltd.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Religare Investment Call

Bajaj Auto Ltd. BUY. August 23, Investor s Rationale. Key Risk:

Maruti Suzuki India Ltd.

SIEMENS INDIA LIMITED RESEARCH

Maruti Suzuki India Ltd.

J.B. Chemicals & Pharmaceuticals Ltd.

Persistent Systems Ltd

Hindustan Unilever Ltd.

BALKRISHNA INDUSTRIES LTD

Bank of Baroda (BOB)

NTPC Ltd. BUY CMP (Rs.) 163 Target (Rs.) 188 Potential Upside 15% For private circulation only. Volume No.. II Issue No. 164.

Reliance Industries Ltd.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Vardhman Textiles BUY. May 30, Investor s Rationale

Religare Investment Call

Amber Enterprises India Ltd

Indian Oil Corporation Ltd.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Procter & Gamble Hygiene & Health Care

Fineotex Chemical Ltd

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Visaka Industries Ltd

Cummins India Ltd Bloomberg Code: KKC IN

Bank of Baroda Ltd. BUY. March 07, s. Investor s Rationale

Aurobindo Pharma Ltd.

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

NIIT Technologies Ltd. (NIIT Tech)

All the more bullish, TP upgraded

Religare Investment Call

Hindustan Media Ventures

ACC Ltd. BUY CMP (Rs.) 1,471 Target (Rs.) 1,655 Potential Upside 13% For private circulation only. Volume No.. II Issue No. 172.

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Religare Investment Call

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Trident Ltd. Buy & Add on dips

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

ABB LTD (INDIA) RESEARCH

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Margins(%) EBITDA 30.0% 26.3% 25.4% NPM 26.5% 12.5% 18.1%

Religare Investment Call

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Key highlights for the year

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

HCL Technologies Ltd.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Maruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Recommendation HOLD Results in line with our expectations CMP (15/10/2010) Rs Target Rs Sector

Mahindra & Mahindra Ltd.

NTPC LIMITED RESEARCH

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

NTPC Ltd. Results in line with estimates, BUY for attractive valuations. Power. EBITDA margins up at 26% (+700bps QoQ): EBITDA margins

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

BUY. NIIT TECHNOLOGIES LTD Result Update (PARENT BASIS): Q2 FY16 SYNOPSIS. CMP Target Price OCTOBER 17 th, 2015

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Transport Corporation of India Ltd.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Havells India. Q4FY16 Result Update In-line result; Consistent improvement in performance. Sector: Consumer Durable CMP: ` 342. Recommendation: BUY

Symphony Ltd. RESULT UPDATE 31st October 2017

Mahindra & Mahindra Ltd.

Ahluwalia Contracts (India)

Religare Investment Call

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

PI Industries. BUY CMP (Rs.) 835 Target (Rs.) 937 Potential Upside 12% For private circulation only. Volume No.. I Issue No. 127.

Century Plyboards India Ltd.

Simplex Infrastructures

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Mahindra & Mahindra Ltd.

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Transcription:

May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15. Volume No.. I Issue No. 18 Hinduja Global Solutions Ltd. May 20 th, 2015 BSE Code: 532859 NSE Code: HGS Reuters Code: HGSL.NS Bloomberg Code: HGSL:IN Incorporated in 2000, as a part of the Hinduja Group, Hinduja Global Solutions Ltd. (HGS) is a leading Business Process Management (BPM) and IT solutions provider to Healthcare/Insurance, Financial Services, Telecommunications and Consumer Products sector. HGS is accredited as one of the foremost players in Contact Center Outsourcing space by the analyst and advisor community. By relating analytics and interaction transformation design to provide innovation and thought leadership, HGS upturns revenue, increases operating efficiency and aids to hold valued customers. Its expertise spans across the telecommunications and media, healthcare, insurance, banking, consumer electronics and technology, retail, consumer packaged goods industries, as well as the public sector. Its client base contains particularly the world's most recognized brands across North America, Europe, Asia and Africa. Investment Rationale Healthcare segment provides high revenue visibility: During Q3FY15, HGS growth was largely driven by the expanding capabilities in its healthcare segment. Over the last few years, it has grown significantly and now contributes 33.8% to the top-line. It has emerged as a leader in providing end-to-end services to the healthcare industry for both payers and providers, including 5 of the top 10 healthcare payers and over 10 large hospital groups in the US. Moreover, its recent acquisition of Colibrium Inc will further aid in developing competences, hence providing HGS a market edge. Client retention-a key growth driver: HGS attributes a large chunk of its revenue to the top 5 clients that the company handles. Moreover, it client tenures comprises of only ~6% of the clients with a relationship of less than 5 years. 94% of the total clients have been with the company for more than 5 years, hence testifying the high execution potential and the quality service of the company. Debt levels to stabilise in the coming years: HGS has registered ~16% CAGR in the debt levels from FY13A leading to a debt of ~`6,047.1 mn accounting for ~38% of the total shareholder s equity at the end of H1FY15 from ~35% in FY13A. This has created a need for the management to address the high debt problem in order to prevent a pile-up in case of future expansion plans. However, we believe that the debt will moderate given no capex plans of the company for the coming years along with the company s efforts to transmit cash from its overseas subsidiary to the domestic business, capturing benefit of the tax window. Market Data Rating One year Price Chart 150 100 50 NIFTY HGS BUY CMP (`) 555 Target (`) 689 Potential Upside ~24% Duration Long Term Face Value (`) 10.0 52 week H/L (`) 736.5/475.0 Adj. all time High (`) 736.5 Decline from 52WH (%) 24.6 Rise from 52WL (%) 16.9 Beta 1.1 Mkt. Cap (`bn) 114.4 Enterprise Value (`bn) 115.3 Fiscal Year Ended Y/E FY14A FY15E FY16E FY17E Revenue (`bn) Net profit (`bn) 25.0 28.7 32.8 37.5 1.6 1.6 2.0 2.3 EPS (`) 12.4 12.2 14.8 16.8 P/E (x) 44.8 45.4 37.5 33.0 P/BV (x) 7.9 7.3 6.6 6.0 ROE (%) 11.7 10.0 11.6 12.0 Shareholding Pattern Mar-15 Dec-14 Chg Promoters 67.7 67.8 (0.1) FII 12.0 12.0 0.0 DII 5.0 5.0 0.0 Others 15.3 15.2 0.1

Hinduja Global Solutions Ltd - a leading BPM and IT solutions provider Hinduja Global solutions Ltd. is a firm involved in the pure play BPO business catering to a wide range of industries spanning from telecom to healthcare. Incorporated in 2000, as a part of the Hinduja Group, Hinduja Global Solutions Ltd. (HGS) is a leading Business Process Management (BPM) and IT solutions provider to Healthcare/Insurance, Financial Services, Telecommunications and Consumer Products sector. HGS is acknowledged as one of the leading players in Contact Center Outsourcing space by the analyst and advisor community. By relating analytics and interaction transformation design to provide innovation and thought leadership, HGS upturns revenue, increases operating efficiency and aids to hold valued customers. HGS expertise spans the telecommunications and media, healthcare, insurance, banking, consumer electronics and technology, retail, consumer packaged goods industries, as well as the public sector. Its client base contains particularly the world's most recognized brands across North America, Europe, Asia and Africa. Earning 15% of its revenues from domestic markets, HGS is one of the top 10 pure play BPO service providers in India. Domestic service includes voice based activities in Banking & Financial Services, Insurance, Telecom and Consumer Durables. HGS operates on a global landscape with 28,000+ employees in 60 worldwide locations delivering localized solutions. HGS commands a worldwide footprint with 58 delivery centers spanning across Italy, India, Jamaica, Canada, France, the Netherlands, the Philippines, the United Kingdom, the United States of America Germany and Mauritius. Over the years, the company has adopted a proactive strategy of organic growth, and has acquired entities in the US, UK, Philippines, Canada and India. Segmental revenue contribution across service HGS s offering mix CRM Non- Voice, Transactio 4.0% n Processin g, 21.0% CRM Voice, 75.0% Offshore, 37.0% Onshore, 63.0% Strong revenue growth bodes well for the company Revenue growth driven by healthcare segment: For the quarter ended December 2014, HGS revenue grew 11.5% YoY and 4.3% QoQ to `7,325.9 mn. The growth was driven by increased contribution from the healthcare vertical. Revenue growth was broad-based across geographies with Philippines being the major contributor. The Philippines operations experienced client expansion. It received two new contracts from a fitness client and a durable medical equipment provider. The company s fifth facility at Alabang continued operating at optimum levels, whereas its sixth facility with a capacity of 420 FTEs started in March 2015, hence will aid to revenues in the upcoming quarters.

The growth in the top-line comes as the healthcare business and the Philippines expansion continues to yield higher sales. Portfolio rationalisation costs hampered EBITDA: EBITDA for the quarter stood at `903.7 mn as against `918.5 mn declining by 1.6% YoY. EBITDA was squeezed by the ongoing ramp-up activities in Philippines and Canada. Cost related to the ongoing portfolio rationalization initiatives also had an adverse impact on the margin. Higher depreciation and ramp-up costs affected the PAT adversely: PAT for Q3FY15 stood at `527.7 mn as against `540.9 mn in Q3FY15 reporting a decline of 2.4% YoY. Profitability was impacted by higher depreciation charge on account of implementation of the new Companies Act. The expansion in the Philippines coupled with the hostile movement of the Canadian dollar also had a negative impact on the bottom-line. However, the management is of the view that the profitability will improve on completion of ramp-ups in Philippines. Moreover, improvement in demand from telecom clients in Canada and steady performance of Europe and US operations strengthens confidence that the growth momentum will continue in the mid to long term. Quarterly performance continue to gain traction 8,000.0 7,000.0 6,000.0 5,000.0 6,569.3 14.0% 6,414.9 13.3% 6,662.2 7,020.7 11.5% 11.5% 7,325.3 12.3% 16.0% 14.0% 12.0% 10.0% `mn 4,000.0 3,000.0 2,000.0 8.2% 5.4% 4.9% 5.5% 7.2% 8.0% 6.0% 4.0% 1,000.0 0.0 918.5 852.8 765.4 809.7 903.7 540.9 349.0 325.0 384.6 527.7 Q3FY14 Q4FY14 Q1FY15 Q2FY15 Q3FY15 Revenue EBITDA PAT EBITDA Margin PAT Margin 2.0% 0.0% The takeover of the US healthcare major Colibrium will give the company access to cloud based software platform to provide automated healthcare services. Acquisition of Colibrium to aid the healthcare segment Over the past few years, HGS healthcare segment has registered significant growth and has emerged as the largest contributor to the revenue, sharing a significant 33.8% of the pie. HGS's Extended Business Office Solutions Practice (HGS EBOS) supplements its clients' efforts in patient access, health information management and patient financial services by delivering solutions for financial clearance, medical coding and insurance claim resolution designed to improve net revenue, reduce bad debt and accelerate cash collections. Recently, the company acquired majority stakes of Colibrium Inc, a Healthcare Technology major in the US that devised a cloud based software platform that works closely by automating capabilities for Healthcare providers. The takeover is expected to offer an edge to Hinduja Global Solutions to upsurge the service competencies in trades and enrolment areas for the Americans as well Global health insurers. For private circulation only

Strong traction from the healthcare business that contributes ~33.8% to the top-line `Mn 8,000.0 7,000.0 6,000.0 5,000.0 4,000.0 4,768.8 22.7 6,212.0 24.8 5,513.9 27.8 7,100.7 33.8 40 35 30 25 20 3,000.0 15 2,000.0 10 1,000.0 5 0.0 FY12 FY13 FY14 9MFY15 0 Client retention reflects quality service HGS long standing client tenures is a testimony for service quality and execution capabilities. HGS has a reputation of thriving on long standing clientele base, which drives a large chunk of its top-line. It draws ~50% of the revenue from its top 5 clients, ~66% from the top 10 clients and 79% from the top 20 clients. Albeit this poses a concentration risk for the company, but HGS has had a majority of them since more than a decade owing to its highquality service delivery. It also recently completed 40 years of service with its top client in the consumer durables sector. The contribution from the top 5 clients increased from 17% in Q3FY12 to 50% in Q3FY15. In addition to this, the company has been able to grow its client base as banking upon expansion in existing capacities, healthy client retention records and entering new geographies. HGS client tenures >10 years, 72% <5 years, 6% 5-10 years, 22% The number of clients (direct and payroll processing clients) have grown at a CAGR of 11.4% over last four years from 482 clients in Q3FY12 to 667 in Q3FY15. These factors give us confidence on the execution capabilities of the company and its service quality, thus making us optimistic about its growth. With no major capex in sight, debt levels are likely to come down HGS has aggressively relied on mergers and acquisitions (M&A) to achieve economies of scale, hurting its balance sheet with debt. The company had a debt of `5,542.8 mn in FY14 and `6,047.1 mn in H1FY15 growing at an average of ~23.2% and 34.4% respectively from FY13. A majority of this is due to Online Support acquisition in FY12, which helped the company gain entry into the Canadian market and the on-going ramp-ups in Philippines. However, we believe that the debt levels will likely retreat going forward. With no large capex or M&A planned, company s requirements for capital will go down generating higher free cash flows and healthy returns. Additionally, the company is progressively transmitting cash from its overseas subsidiary to the domestic business, capturing benefit of the tax window available to it.

` Mn All these factors direct to a healthier balance sheet moving forward. All put together, the management expects to moderate debt considerably by Sep 18. Debt likely to stabilise in the coming years HGS has no major capex planned for FY16 and FY17; hence we believe that the company s 6,200 6,100 6,000 5,900 5,800 6,113.7 5,801.5 5,843.7 borrowings are likely to go down. 5,700 5,600 5,500 5,542.8 5,400 5,300 5,200 FY14A FY15E FY16E FY17E Key risks Given a vast global presence, the company is exposed to currency risk. Being a pure play BPO service provider, HGS stands to lose if integrated IT-BPM players expand. HGS faces tough competition from MNCs and Indian BPM-IT vendors. HGS relies heavily on its top clients and draws a major share of its revenue from them which expose it to concentration risk. Healthy returns going ahead 12.5 12.0 11.7 11.6 12.0 11.9 12.5 12.0 11.5 11.5 11.4 11.0 11.0 10.5 11.1 10.0 10.6 10.5 10.0 9.5 10.0 FY14A FY15E FY16E FY17E ROA (%) ROE (%) 9.0

Balance Sheet (Consolidated) Y/E (`mn) FY14A FY15E FY16E FY17E Share Capital 206.2 206.2 206.2 206.2 Reserve and surplus 14,314.5 15,457.5 17,030.4 19,004.6 Net Worth 14,520.6 15,663.7 17,236.6 19,210.7 Minority Interest 0.1 0.0 0.0 0.0 Loans 5,542.9 6,113.7 5,801.5 5,843.7 Deferred tax liability 297.3 217.0 217.0 217.0 Long term Provisions 64.0 70.2 77.3 77.3 Current Liabilities 3,872.4 3,118.3 3,239.1 3,300.4 Capital Employed 24,297.3 25,182.9 26,571.5 28,649.1 Fixed Assets 10,902.9 12,089.2 13,404.5 14,863.0 Long term loans and 1,364.6 1,530.8 1,717.3 1,926.5 advances Non- Current Investments 68.5 79.2 79.2 79.2 Other noncurrent assets 77.7 69.5 69.5 69.5 Current Assets 11,883.7 11,414.2 11,301.0 11,710.9 Capital Deployed 24,297.3 25,182.9 26,571.5 28,649.1 Profit & Loss Account (Consolidated) Y/E (`mn) FY14A FY15E FY16E FY17E Net Sales 25,048.5 28,664.9 32,792.6 37,514.7 Expenses 21,829.6 25,270.6 28,964.2 33,197.8 EBITDA 3,219.0 3,394.3 3,828.4 4,316.9 Other Income 340.0 242.7 259.7 277.8 Depreciation 862.0 955.0 1,059.0 1,174.2 EBIT 2,697.0 2,681.9 3,029.1 3,420.6 Net cost Interest Profit Before Tax 387.5 458.5 435.1 438.3 2,309.5 2,223.4 2,594.0 2,982.3 Tax 681.7 655.9 596.6 685.9 Net Profit 1,627.8 1,567.5 1,997.4 2,296.4 Key Ratios (Consolidated) Y/E FY14A FY15E FY16E FY17E EBITDA Margin (%) EBIT Margin (%) 12.9 11.8 11.7 11.5 10.8 9.4 9.2 9.1 NPM (%) 6.5 5.5 6.1 6.1 ROCE (%) 13.9 12.8 13.5 14.0 ROE (%) 11.7 10.0 11.6 12.0 EPS (`) 12.4 12.2 14.8 16.8 P/E (x) 44.8 45.4 37.5 33.0 BVPS(`) 70.4 76.0 83.6 93.2 P/BVPS (x) 7.9 7.3 6.6 6.0 EV/Operating Income (x) 32.4 32.4 28.9 25.7 Valuation and view Over the years, HGS has been capitalising on its strong clientele base, technical expertise and successful acquisitions in order to strengthen its balance sheet and increase its revenues. Given its pure play BPO services and its market standing, we believe that the company is in a favourable position to further leverage on its expanding capacities in the Healthcare and the telecom segments. We expect HGS net profit to grow at a CAGR of ~11% during FY14-FY16E and believe that it will continue to deliver strong return ratios as well. At the current market price (CMP) of `555.5, the stock trades at a P/E of 37.5x FY16E and 33x FY17E. We recommend BUY with a target price of `689.0, which implies a potential upside of ~24% to the CMP from a long term perspective. EV/EBITDA (x) 35.8 34.7 30.8 27.3 For private circulation only

Disclaimer : This document has been prepared by Funds India and Dion Global Solution Ltd. (the company) and is being distributed in India by Funds India. The information in the document has been compiled by the research department. Due care has been taken in preparing the above document. However, this document is not, and should not be construed, as an offer to sell or solicitation to buy any securities. Any act of buying, selling or otherwise dealing in any securities referred to in this document shall be at investor s sole risk and responsibility. This document may not be reproduced, distributed or published, in whole or in part, without prior permission from the Company. Copyright 2014 - Dion Global Solution Ltd and Funds India. Contact Us: Fund India H.M Center, Second Floor, 29, Nungambakkam High Road, Nungambakkam, Chennai - 600 034. T: +91 7667 166 166 Email: contact@fundsindia.com